INPP5D has been implicated in modulating downstream signaling pathways associated with multiple immune receptors involved in AD pathogenesis, such as TREM2, TYROBP (DAP12), CLEC7A, and FCγRs.9, 10, 11, 12. This evidence concerns the gene TYROBP and Alzheimer disease.